Clinical trial

Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy

NCT00723918

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention SAB378 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record methadone Normalized identity: methadoneView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention SAB placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Methadone placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2009-04-01

PhasePHASE2

Conditions

HIV-associated Neuropathyunresolved

Polyneuropathyverified · MONDO: polyneuropathy

Interventions

SAB378DRUG

methadoneDRUG · verified · RxNorm: methadone

SAB placeboDRUG

Methadone placeboDRUG

Sponsors & collaborators

Washington University School of Medicinelead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)collaborator

Mapped research locations

San DiegoCalifornia, United States1 RochesterNew York, United States1 BrooklynNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00723918 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.